Tag: sgRNA

Functional genomic screening in Komagataella phaffii enabled by high-activity CRISPR-Cas9 library

Abstract CRISPR-based high-throughput genome-wide loss-of function screens are a valuable approach to functional genetics and strain engineering. The yeast Komagataella phaffii is a host of particular interest in the biopharmaceutical industry and as a metabolic engineering host for proteins and metabolites. Here, we design and validate a highly active 6-fold…

Continue Reading Functional genomic screening in Komagataella phaffii enabled by high-activity CRISPR-Cas9 library

SGRNA Requirement (pdf) – Course Sidekick

PROJECT TITLE: AN IMPROVED DEEP LEARNING METHOD TO PREDICT THE ABILITY OF SGRNA OFF-TARGET PROPENSITY Download all the required/available files from gdrive (3.5MB): drive.google.com/drive/folders/1rDPcagh_iWWV1W9OWdIn8BeVnKdsxWSl?usp=sharing Project Objectives: (a) To review prediction of deep learning method for sgRNA off-target propensity. (b) To model the prediction of sgRNA off-target propensity using CnnCrispr. (c)…

Continue Reading SGRNA Requirement (pdf) – Course Sidekick

G7250D | Agilent

Please login to add product to your favorites. Part Number SureGuide sgRNA, 500ug, 90-120nt Add to Favorites + Create New list Item successfully added to your list Read more here: Source link

Continue Reading G7250D | Agilent

Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly

Capturing proteins associated with SARS-CoV-2 virions To identify host cell proteins potentially present in extracellular SARS-CoV-2 virions, viral particles were produced from two lung epithelial cell models, A549 cells overexpressing ACE2 receptor (A549-ACE2) and Calu-3 cells that naturally express ACE2 receptor and TMPRSS2. Following infection with the D614G SARS-CoV-2 strain32,…

Continue Reading Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly

Crispr Library Download

CRISPR guide RNA libraries have been iteratively improved to provide increasingly efficient reagents, although their large size is a barrier for many applications. We design an optimised minimal genome-wide human CRISPR-Cas9 library (MinLibCas9) by mining existing large-scale gene loss-of-function datasets, resulting in a greater than 42% reduction in size compared…

Continue Reading Crispr Library Download

Pharmaceutics | Free Full-Text | Natural Biopolymer-Based Delivery of CRISPR/Cas9 for Cancer Treatment

Cancer is one of the leading causes of disease-associated mortality, with a rising incidence worldwide [1]. Although many therapeutic methods have been used in cancer treatment, such as chemotherapy, radiotherapy, surgery, and targeted therapy, the overall therapeutic outcome remains unsatisfactory. Therefore, developing new therapeutic means is urgently needed. With advances…

Continue Reading Pharmaceutics | Free Full-Text | Natural Biopolymer-Based Delivery of CRISPR/Cas9 for Cancer Treatment

Summary of Genomics and Transcriptomics – DNA sequencing I. Goal II. Methodology A. Sanger DNA

DNA sequencing I. Goal II. Methodology A. Sanger DNA sequencing ● Up to 900 base pairs ● Primer extension with labeled ddNTPs (radioactive or fluorescent) ● Prior knowledge on target needed ● Difficult to detect variation in mixtures ● High accuracy + still in use for genotyping When it is…

Continue Reading Summary of Genomics and Transcriptomics – DNA sequencing I. Goal II. Methodology A. Sanger DNA

First patient dosed in clinical trial of YOLT-201 for treatment of hereditary ATTR-CM

SHANGHAI, Dec. 17, 2023 /PRNewswire/ — Yoltech Therapeutics today announced that the first patient has been administered a dose of YOLT-201, the company’s first in vivo genome editing candidate being developed as a single dose, Which is a potentially curative therapy for hereditary transthyretin amyloidosis. With cardiomyopathy (ATTR-CM). The study…

Continue Reading First patient dosed in clinical trial of YOLT-201 for treatment of hereditary ATTR-CM

First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM

SHANGHAI, Dec. 17, 2023 /PRNewswire/ — YolTech Therapeutics today announced that the first patient has been dosed with YOLT-201, the company’s first in vivo genome editing candidate being developed as a single dose, potentially curative therapy for hereditary transthyretin amyloidosis with cardiomyopathy (ATTR-CM). The study by YolTech is a single-arm,…

Continue Reading First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM

Solved R plasmid R determinant CRISPR tracrRNA sgRNA E |||

R plasmid R determinant CRISPR tracrRNA sgRNA E ||| ||| E ||| ||| A gene that induces antibiotic-resistance. Small circle of extragenomic DNA that contains antibiotic resistant genes. Clustered regularly interspaced short palindromic sequences in bacterial that contain repetitive viral information that can be expressed to interfere with viral DNA…

Continue Reading Solved R plasmid R determinant CRISPR tracrRNA sgRNA E |||

Lentiviral KCNT2 HUMAN sgRNA gene Knockout/Screening Kit -FenicsBIO

Lentiviral KCNT2 HUMAN sgRNA gene Knockout/Screening Kit -FenicsBIO The store will not work correctly when cookies are disabled. JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser. We use cookies to give you the…

Continue Reading Lentiviral KCNT2 HUMAN sgRNA gene Knockout/Screening Kit -FenicsBIO

Solved Part 1. Answer Pre-Laboratory Questions Table 2.

Part 1. Answer Pre-Laboratory Questions Table 2. Starter plate conditions. Starter Plate IX IX/ARA Plate Additives IPTG, X-gal IPTG, X-gal, arabinose explorer.bio-rad.com Bacterial Colony Color Blue Blue Casg + DNA Repair System nop OFF ON sgRNA Student Guide A. Using evidence from Table 2, explain in complete sentences why the…

Continue Reading Solved Part 1. Answer Pre-Laboratory Questions Table 2.

Catalytically inactive dKbCas12d guided by sgRNA and new insights into its binding through a single-molecule approach

Abstract CRISPR-Cas12d is a distinct V-D type system discovered in the metagenomes of Candidate Phyla Radiation bacteria. It stands out from most closely related systems due to its 17-19 nucleotide short spacer region and specialized stabilizing scoutRNAs. We made significant improvements to this system by modifying its scoutRNA to create…

Continue Reading Catalytically inactive dKbCas12d guided by sgRNA and new insights into its binding through a single-molecule approach

Solved 6. A few years ago I set up a cross between BDSC

Transcribed image text: 6. A few years ago I set up a cross between BDSC \#79543 females and \#51324 males. Here are the relevant parts of their genotypes: #79543 = P{TKO.GS02468}attP40/CyO  [P\{TKO.GS02468\}attP40 is an inserted element on chromosome 2 that expresses an sgRNA for Cas9-mediated mutagenesis of the white gene] #51324=w; PBac {y[+ mDint2] GFP[E.3xP3]=vas-Cas9}VK00027  […

Continue Reading Solved 6. A few years ago I set up a cross between BDSC

What is the mechanism of action of Irf5 siRNA-loaded biodegradable lipid nanoparticles?

How can lipid particles for RNA delivery be prepared by self-assembly?3 answersLipid particles for RNA delivery can be prepared by self-assembly through the use of lipid nanoparticles (LNPs). LNPs are lipid vesicles with a homogeneous lipid core that protect mRNA from degradation and assist with intracellular delivery. The self-assembly of…

Continue Reading What is the mechanism of action of Irf5 siRNA-loaded biodegradable lipid nanoparticles?

Generation of 17C-2 iCas9 hiPSCs containing a custom CRISPR library (17C-2-CC) by lentiviral transduction, associated with Fig 2.

(A) (left) Phase-contrast images of lenti-viral transduced 17C-2 hiPSCs before (day 1) and after (day 3) puromycin selection. Volumes of virus-containing supernatant added per well (0 μl, 8 μl and 16 μl; virus titer) are indicated. (+), with puromycin; (-), without puromycin. (right) The number of cells counted at day…

Continue Reading Generation of 17C-2 iCas9 hiPSCs containing a custom CRISPR library (17C-2-CC) by lentiviral transduction, associated with Fig 2.

Generating a New sgRNA Vector, pGL3-U6-sgRNA-PGK-mRFP-T2A-PuroR, to Improve Base Editing

doi: 10.32371/jger/246146. Epub 2022 Dec 17. Affiliations Expand Affiliation 1 Center for Molecular and Cellular Biosciences, School of Biological, Environmental, and Earth Sciences, University of Southern Mississippi, Hattiesburg, Mississippi 39406, United States of America. Free PMC article Item in Clipboard Tolulope E Ayo et al. J Genome Ed Regul. 2022. Free…

Continue Reading Generating a New sgRNA Vector, pGL3-U6-sgRNA-PGK-mRFP-T2A-PuroR, to Improve Base Editing

Addgene: pAAV-U6-sgRNA(OXTR.1)-CMV-eGFP Sequences

> Addgene NGS Result CCTGCAGGCAGCTGCGCGCTCGCTCGCTCACTGAGGCCGCCCGGGCGTCGGGCGACCTTTGGTCGCCCGG CCTCAGTGAGCGAGCGAGCGCGCAGAGAGGGAGTGGCCAACTCCATCACTAGGGGTTCCTGCGGCCGCAC GCGTGAGGGCCTATTTCCCATGATTCCTTCATATTTGCATATACGATACAAGGCTGTTAGAGAGATAATT GGAATTAATTTGACTGTAAACACAAAGATATTAGTACAAAATACGTGACGTAGAAAGTAATAATTTCTTG GGTAGTTTGCAGTTTTAAAATTATGTTTTAAAATGGACTATCATATGCTTACCGTAACTTGAAAGTATTT CGATTTCTTGGCTTTATATATCTTGTGGAAAGGACGAAACACCGGTGCTTCATGAAAAAGAAGGTTTTAG AGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCT TTTTTTCTAGAGGGTACCGGGGCCCGGTCGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTC ATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGA CCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGACTTTCCATTGACGT CAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGC CCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTT TCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTACATC AATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTT TGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGG CGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTGGTTTAGTGAACCGTCAGATCCGCTAGCGC TACCGGTCGCCACCATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCT GGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAG CTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGA CCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCAT GCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAG GTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCA ACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAA GAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCAC TACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGT CCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGG GATCACTCTCGGCATGGACGAGCTGTACAAGTCCGGACTCAGATCTCGATAACCTGCAGCGAATTCGATA TCAAGCTTATCGATACCGAGCGCTGCTCGAGAGATCTACGGGTGGCATCCCTGTGACCCCTCCCCAGTGC CTCTCCTGGCCCTGGAAGTTGCCACTCCAGTGCCCACCAGCCTTGTCCTAATAAAATTAAGTTGCATCAT TTTGTCTGACTAGGTGTCCTTCTATAATATTATGGGGTGGAGGGGGGTGGTATGGAGCAAGGGGCAAGTT GGGAAGACAACCTGTAGGGCCTGCGGGGTCTATTGGGAACCAAGCTGGAGTGCAGTGGCACAATCTTGGC TCACTGCAATCTCCGCCTCCTGGGTTCAAGCGATTCTCCTGCCTCAGCCTCCCGAGTTGTTGGGATTCCA GGCATGCATGACCAGGCTCAGCTAATTTTTGTTTTTTTGGTAGAGACGGGGTTTCACCATATTGGCCAGG CTGGTCTCCAACTCCTAATCTCAGGTGATCTACCCACCTTGGCCTCCCAAATTGCTGGGATTACAGGCGT GAACCACTGCTCCCTTCCCTGTCCTTCTGATTTTGTAGGTAACCACGTGCGGACCGAGCGGCCGCAGGAA CCCCTAGTGATGGAGTTGGCCACTCCCTCTCTGCGCGCTCGCTCGCTCACTGAGGCCGGGCGACCAAAGG TCGCCCGACGCCCGGGCTTTGCCCGGGCGGCCTCAGTGAGCGAGCGAGCGCGCAGCTGCCTGCAGGGGCG CCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATACGTCAAAGCAACCATAGT ACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGC CAGCGCCTTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGT CAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAAC TTGATTTGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGA GTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACTCTATCTCGGGCTATTCT TTTGATTTATAAGGGATTTTGCCGATTTCGGTCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTA ACGCGAATTTTAACAAAATATTAACGTTTACAATTTTATGGTGCACTCTCAGTACAATCTGCTCTGATGC CGCATAGTTAAGCCAGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCG…

Continue Reading Addgene: pAAV-U6-sgRNA(OXTR.1)-CMV-eGFP Sequences

RPS15A sgRNA-2 lentiCRISPR v2 plasmid Sequences

> Addgene NGS Result AACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCC TATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTAATTCTGTGGAATGTGTGTCAGTT AGGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCA ACCAGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAG CAACCATAGTCCCGCCCCTAACTCCGCCCATCCCGCCCCTAACTCCGCCCAGTTCCGCCCATTCTCCGCC CCATGGCTGACTAATTTTTTTTATTTATGCAGAGGCCGAGGCCGCCTCTGCCTCTGAGCTATTCCAGAAG TAGTGAGGAGGCTTTTTTGGAGGCCTAGGCTTTTGCAAAAAGCTCCCGGGAGCTTGTATATCCATTTTCG GATCTGATCAGCACGTGTTGACAATTAATCATCGGCATAGTATATCGGCATAGTATAATACGACAAGGTG AGGAACTAAACCATGGCCAAGTTGACCAGTGCCGTTCCGGTGCTCACCGCGCGCGACGTCGCCGGAGCGG TCGAGTTCTGGACCGACCGGCTCGGGTTCTCCCGGGACTTCGTGGAGGACGACTTCGCCGGTGTGGTCCG GGACGACGTGACCCTGTTCATCAGCGCGGTCCAGGACCAGGTGGTGCCGGACAACACCCTGGCCTGGGTG TGGGTGCGCGGCCTGGACGAGCTGTACGCCGAGTGGTCGGAGGTCGTGTCCACGAACTTCCGGGACGCCT CCGGGCCGGCCATGACCGAGATCGGCGAGCAGCCGTGGGGGCGGGAGTTCGCCCTGCGCGACCCGGCCGG CAACTGCGTGCACTTCGTGGCCGAGGAGCAGGACTGACACGTGCTACGAGATTTCGATTCCACCGCCGCC TTCTATGAAAGGTTGGGCTTCGGAATCGTTTTCCGGGACGCCGGCTGGATGATCCTCCAGCGCGGGGATC TCATGCTGGAGTTCTTCGCCCACCCCAACTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAATAG CATCACAAATTTCACAAATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTTTGTCCAAACTCATCAAT GTATCTTATCATGTCTGTATACCGTCGACCTCTAGCTAGAGCTTGGCGTAATCATGGTCATAGCTGTTTC CTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTG GGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAAC CTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTT CCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAA GGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAA AAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATC ACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCC TGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCT TCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCA AGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGA GTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGG TATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTG GTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAAC CACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAA GATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCA TGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAG TATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGT CTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCAT CTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCA GCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGT TGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCA TCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTAC ATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTG GCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGAT GCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTC TTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAA CGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTG CACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAA…

Continue Reading RPS15A sgRNA-2 lentiCRISPR v2 plasmid Sequences

DNA polymerases in precise and predictable CRISPR/Cas9-mediated chromosomal rearrangements | BMC Biology

Cell culture The human endometrial carcinoma HEC-1-B cells were cultured in the modified Eagle’s medium (MEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin at 37°C in a 5% (v/v) CO2 incubator. The human embryonic kidney HEK293T cells were cultured in the Dulbecco’s modified Eagle’s medium (DMEM) supplemented…

Continue Reading DNA polymerases in precise and predictable CRISPR/Cas9-mediated chromosomal rearrangements | BMC Biology

Shaping the Future of Targeted Drug Development

The need for targeted drugsCRISPR/Cas9 in drug discoveryPrecision medicine and personalized therapiesFuture prospects and conclusionsReferences Further reading  Clustered regular interspaced short palindromic repeat/CRISPR-associated 9 (CRISPR/Cas9) is a gene-editing technology that has revolutionized biomedical research since its original publication in 2012. The two primary components involved in CRISPR/Cas9 include a guide ribonucleic…

Continue Reading Shaping the Future of Targeted Drug Development

Native ribonucleases process sgRNA transcripts to create catalytic Cas9/sgRNA complexes in planta

Native ribonucleases process sgRNA transcripts to create catalytic Cas9/sgRNA complexes in planta – Texas A&M University (TAMU) Scholar Search form   Overview   Identity   Other   View All   Overview abstract The current CRISPR/Cas9 gene editing dogma for single guide RNAs (sgRNA) delivery is based on the premise that…

Continue Reading Native ribonucleases process sgRNA transcripts to create catalytic Cas9/sgRNA complexes in planta

Addgene: CAGGS-AsCpf1-2A-GFP-U6-AAVS1-MAFB-sgRNA

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications. For your Materials & Methods section: CAGGS-AsCpf1-2A-GFP-U6-AAVS1-MAFB-sgRNA was a gift from Rudolf Jaenisch (Addgene plasmid # 194725…

Continue Reading Addgene: CAGGS-AsCpf1-2A-GFP-U6-AAVS1-MAFB-sgRNA

From resistance to resilience: Reprogramming

image:  Vincristine monotherapy triggers NF-κB activation, inducing OIP5 expression linked to cancer cell resistance against vincristine. The engineered sgRNA, housing the NF-κB aptamer, competitively binds with NF-κB, leading to a conformational change from inactive state to active state that frees sgRNA’s guide region. This guides NF-κB to downregulate OIP5 expression…

Continue Reading From resistance to resilience: Reprogramming

Tune Therapeutics Presents Data for Hepatitis B Epigenetic Silencer

By Jonathan D. Grinstein, PhD When Brian Cosgrove, PhD, Principal Scientist at Tune Therapeutics, was thinking of what to go after with epigenetic editing, generating first-in-class viral therapeutics—in particular, the hepatitis B virus (HBV)—wasn’t necessarily the first thing that came to mind. “We started linking up some of the biology…

Continue Reading Tune Therapeutics Presents Data for Hepatitis B Epigenetic Silencer

Epigenetic Editing Holds Promise for Hepatitis B Treatment

Researchers at Tune Therapeutics are exploring the potential of epigenetic editing to develop viral therapeutics for hepatitis B (HBV). The company, led by Principal Scientist Brian Cosgrove, hopes to achieve a functional cure for the disease by targeting the unique epigenetic regulation of HBV. By silencing key viral persistence and…

Continue Reading Epigenetic Editing Holds Promise for Hepatitis B Treatment

Map of disease-causing mutations in neurodevelopmental disorders and cancer revealed

Experimental design overview. a Two independent sgRNAs and associated HDR variant libraries are designed at the 5′ and 3′ end of each exon. b The sgRNA, together with the HDR template library are transfected into LIG4-KO Cas9-expressing HAP1 cells. HDR utilizes the library as a template for repair of the…

Continue Reading Map of disease-causing mutations in neurodevelopmental disorders and cancer revealed

Mechanism of the engineered sg [IMAGE]

Caption Vincristine monotherapy triggers NF-κB activation, inducing OIP5 expression linked to cancer cell resistance against vincristine. The engineered sgRNA, housing the NF-κB aptamer, competitively binds with NF-κB, leading to a conformational change from inactive state to active state that frees sgRNA’s guide region. This guides NF-κB to downregulate OIP5 expression…

Continue Reading Mechanism of the engineered sg [IMAGE]

pHDE-AtU626-lpa1-ipk-ipk1A(mays)-sgRNA-mCherry-UBQ-35S-Cas9 Plasmid

Catalog No.: PVT47385 pHDE-AtU626-lpa1-ipk-ipk1A(mays)-sgRNA-mCherry-UBQ-35S-Cas9 Plasmid Alias:Gene length:Host: Plant Use(s): gene editingFragment Type: CRISPR Fragmented species: Prokaryotic resistance: Spe Screening Markers: Hyg Red Promoter: 35S replicon: pVS1 Copy Number: Competent cells: DH5a Temperature: 30Degrees Back Bones: Forward primer: Reverse primer: Induction method: Sequence:GTTTACCCGCCAATATATCCTGTCAAACACTGATAGTTTAAACTAGTAGTGTGCTGGAATTGCCCTTAAGCTTCGTTGAACAACGGAAACTCGACTTGCCTTCCGCACAATACATCATTTCTTCTTAGCTTTTTTTCTTCTTCTTCGTTCATACAGTTTTTTTTTGTTTATCAGCTTACATTTTCTTGAACCGTAGCTTTCGTTTTCTTCTTTTTAACTTTCCATTCGGAGTTTTTGTATCTTGTTTCATAGTTTGTCCCAGGATTAGAATGATTAGGCATCGAACCTTCAAGAATTTGATTGAATAAAACATCTTCATTCTTAAGATATGAAGATAATCTTCAAAAGGCCCCTGGGAATCTGAAAGAAGAGAAGCAGGCCCATTTATATGGGAAAGAACAATAGTATTTCTTATATAGGCCCATTTAAGTTGAAAACAATCTTCAAAAGTCCCACATCGCTTAGATAAGAAAACGAAGCTGAGTTTATATACAGCTAGAGTCGAAGTAGTGATTGGctacggcgaaaagagtctcgGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCtctactatcgtctatactcgGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCcatgttatgagccaacacctGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTTTGTCCCTTCGAAGGGCAATTCTGCAGATATCCATCACACTGGGaagtgAagcttGGTCTCaACTATGAGACCtaagctggcacaactatatttccaacatcactagctaccatcaaaagattgacttctcatcttactcgattgaaaccaaattaacatagggtttttatttaaataaaagtttaaccttctttttaaaaaattgttcatagtgtcatgtcagaacaagagctacaaatcacacatagcatgcataagcggagctatgatgagtggtattgttttgttcgtcacttgtcactcttttccaacacataatcccgacaacaacgtaagagcatctctctctctccacacacactcatgcatgcatgcattcttacacgtgattgccatgcaaatctcctttctcacctataaatacaaaccaacccttcactacactcttcactcaaaccaaaacaagaaaacatacacaaatagcaaaacggtaccAACAATGGATAACATGGCCATCATCAAGGAGTTCATGCGCTTCAAGGTGCACATGGAGGGCTCCGTGAACGGCCACGAGTTCGAGATCGAGGGCGAGGGCGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGACCAAGGGTGGCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCCTCAGTTCATGTACGGCTCCAAGGCCTACGTGAAGCACCCCGCCGACATCCCCGACTACTTGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGAGGACGGCGGCGTGGTGACCGTGACCCAGGACTCCTCCCTGCAGGACGGCGAGTTCATCTACAAGGTGAAGCTGCGCGGCACCAACTTCCCCTCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTGGGAGGCCTCCTCCGAGCGGATGTACCCCGAGGACGGCGCCCTGAAGGGCGAGATCAAGCAGAGGCTGAAGCTGAAGGACGGCGGCCACTACGACGCTGAGGTCAAGACCACCTACAAGGCCAAGAAGCCCGTGCAGCTGCCCGGCGCCTACAACGTCAACATCAAGTTGGACATCACCTCCCACAACGAGGACTACACCATCGTGGAACAGTACGAACGCGCCGAGGGCCGCCACTCCACCGGCGGCATGGACGAGCTGTACAAGTGAgagctcttggactcccatgttggcaaaggcaaccaaacaaacaatgaatgatccgctcctgcatatggggcggtttgagtatttcaactgccatttgggctgaattgaagacatgctcctgtcagaaattccgtgatcttactcaatattcagtaatctcggccaatatcctaaatgtgcgtggctttatctgtctttgtattgtttcatcaattcatgtaacgtttgcttttcttatgaattttcaaataaattatcGTATtGAGACCgAATTCtcgTCGACGAGTCAGTAATAAACGGCGTCAAAGTGGTTGCAGCCGGCACACACGAGTCGTGTTTATCAACTCAAAGCACAAATACTTTTCCTCAACCTAAAAATAAGGCAATTAGCCAAAAACAACTTTGCGTGTAAACAACGCTCAATACACGTGTCATTTTATTATTAGCTATTGCTTCACCGCCTTAGCTTTCTCGTGACCTAGTCGTCCTCGTCTTTTCTTCTTCTTCTTCTATAAAACAATACCCAAAGAGCTCTTCTTCTTCACAATTCAGATTTCAATTTCTCAAAATCTTAAAAACTTTCTCTCAATTCTCTCTACCGTGATCAAGGTAAATTTCTGTGTTCCTTATTCTCTCAAAATCTTCGATTTTGTTTTCGTTCGATCCCAATTTCGTATATGTTCTTTGGTTTAGATTCTGTTAATCTTAGATCGAAGACGATTTTCTGGGTTTGATCGTTAGATATCATCTTAATTCTCGATTAGGGTTTCATAGATATCATCCGATTTGTTCAAATAATTTGAGTTTTGTCGAATAATTACTCTTCGATTTGTGATTTCTATCTAGATCTGGTGTTAGTTTCTAGTTTGTGCGATCGAATTTGTCGATTAATCTGAGTTTTTCTGATTAACAGCTCGCAATTGACCTAACTGAGTAAGCTAGCTTGTTCGAGTATTATGGCATTGGGAAAACTGTTTTTCTTGTACCATTTGTTGTGCTTGTAATTTACTGTGTTTTTTATTCGGTTTTCGCTATCGAACTGTGAAATGGAAATGGATGGAGAAGAGTTAATGAATGATATGGTCCTTTTGTTCATTCTCAAATTAATATTATTTGTTTTTTCTCTTATTTGTTGTGTGTTGAATTTGAAATTATAAGAGATATGCAAACATTTTGTTTTGAGTAAAAATGTGTCAAATCGTGGCCTCTAATGACCGAAGTTAATATGAGGAGTAAAACACTAGATCCCCAAACAAGCTTGAAACTGAAGGCGGGAAACGACAATCTGATCATGAGCGGAGAATTAAGGGAGTCACGTTATGACCCCCGCCGATGACGCGGGACAAGCCGTTTTACGTTTGGAACTGACAGAACCGCAACGTTGAAGGAGCCACTCAGCCGCGGGTTTCTGGAGTTTAATGAGCTAAGCACATACGTCAGAAACCATTATTGCGCGTTCAAAAGTCGCCTAAGGTCACTATCAGCTAGCAAATATTTCTTGTCAAAAATGCTCCACTGACGTTCCATAAATTCCCCTCGGTATCCAATTAGAGTCTCATATTCACTCTCAATCCAAATAATCTGCACCGGATCCGCTAGAGGATCTCGACCTGCAAGATCCCGGGGGGCAATGAGATATGAAAAAGCCTGAACTCACCGCGACGTCTGTCGAGAAGTTTCTGATCGAAAAGTTCGACAGCGTCTCCGACCTGATGCAGCTCTCGGAGGGCGAAGAATCTCGTGCTTTCAGCTTCGATATAGGAGGGCGTGGATATGTCCTGCGGGTAAATAGCTGCGCCGATGGTTTCTACAAAGATCGTTATGTTTATCGGCACTTTGCATCGGCCGCGCTCCCGATTCCGGAAGTGCTTGACATTGGGGAATTCAGCGAGAGCCTGACCTATTGCATCTCCCGCCGTGCACAGGGTGTCACGTTGCAAGACCTGCCTGAAACCGAACTGCCCGCTGTTCTGCAGCCGGTCGCGGAGGCCATGGATGCGATCGCTGCGGCCGATCTTAGCCAGACGAGCGGGTTCGGCCCATTCGGACCGCAAGGAATCGGTCAATACACTACATGGCGTGATTTCATATGCGCGATTGCTGATCCCCATGTGTATCACTGGCAAACTGTGATGGACGACACCGTCAGTGCGTCCGTCGCGCAGGCTCTCGATGAGCTGATGCTTTGGGCCGAGGACTGCCCCGAAGTCCGGCACCTCGTGCACGCGGATTTCGGCTCCAACAATGTCCTGACGGACAATGGCCGCATAACAGCGGTCATTGACTGGAGCGAGGCGATGTTCGGGGATTCCCAATACGAGGTCGCCAACATCTTCTTCTGGAGGCCGTGGTTGGCTTGTATGGAGCAGCAGACGCGCTACTTCGAGCGGAGGCATCCGGAGCTTGCAGGATCGCCGCGGCTCCGGGCGTATATGCTCCGCATTGGTCTTGACCAACTCTATCAGAGCTTGGTTGACGGCAATTTCGATGATGCAGCTTGGGCGCAGGGTCGATGCGACGCAATCGTCCGATCCGGAGCCGGGACTGTCGGGCGTACACAAATCGCCCGCAGAAGCGCGGCCGTCTGGACCGATGGCTGTGTAGAAGTACTCGCCGATAGTGGAAACCGACGCCCCAGCACTCGTCCGGGATCTTGGAGGTGATGTAACATGATCACAAGCTGATCCCCCGAATTTCCCCGATCGTTCAAACATTTGGCAATAAAGTTTCTTAAGATTGAATCCTGTTGCCGGTCTTGCGATGATTATCATATAATTTCTGTTGAATTACGTTAAGCATGTAATAATTAACATGTAATGCATGACGTTATTTATGAGATGGGTTTTTATGATTAGAGTCCCGCAATTATACATTTAATACGCGATAGAAAACAAAATATAGCGCGCAAACTAGGATAAATTATCGCGCGCGGTGTCATCTATGTTACTAGATCGGGAATTGATCCCCCCTCGACAGCTTGCATGCCAGCTTGGGCTGCAGGTCGACGCGTCAACATGGTGGAGCACGACACTCTCGTCTACTCCAAGAATATCAAAGATACAGTCTCAGAAGACCAAAGGGCTATTGAGACTTTTCAACAAAGGGTAATATCGGGAAACCTCCTCGGATTCCATTGCCCAGCTATCTGTCACTTCATCAAAAGGACAGTAGAAAAGGAAGGTGGCACCTACAAATGCCATCATTGCGATAAAGGAAAGGCTATCGTTCAAGATGCCTCTGCCGACAGTGGTCCCAAAGATGGACCCCCACCCACGAGGAGCATCGTGGAAAAAGAAGACGTTCCAACCACGTCTTCAAAGCAAGTGGATTGATGTGATATCTCCACTGACGTAAGGGATGACGCACAATCCCACTATCCTTCGCAAGACCCTTCCTCTATATAAGGAAGTTCATTTCATTTGGAGAGGACACGATATGGACAAGAAGTACTCCATTGGGCTCGATATCGGCACAAACAGCGTCGGCTGGGCCGTCATTACGGACGAGTACAAGGTGCCGAGCAAAAAATTCAAAGTTCTGGGCAATACCGATCGCCACAGCATAAAGAAGAACCTCATTGGCGCCCTCCTGTTCGACTCCGGGGAGACGGCCGAAGCCACGCGGCTCAAAAGAACAGCACGGCGCAGATATACCCGCAGAAAGAATCGGATCTGCTACCTGCAGGAGATCTTTAGTAATGAGATGGCTAAGGTGGATGACTCTTTCTTCCATAGGCTGGAGGAGTCCTTTTTGGTGGAGGAGGATAAAAAGCACGAGCGCCACCCAATCTTTGGCAATATCGTGGACGAGGTGGCGTACCATGAAAAGTACCCAACCATATATCATCTGAGGAAGAAGCTTGTAGACAGTACTGATAAGGCTGACTTGCGGTTGATCTATCTCGCGCTGGCGCATATGATCAAATTTCGGGGACACTTCCTCATCGAGGGGGACCTGAACCCAGACAACAGCGATGTCGACAAACTCTTTATCCAACTGGTTCAGACTTACAATCAGCTTTTCGAAGAGAACCCGATCAACGCATCCGGAGTTGACGCCAAAGCAATCCTGAGCGCTAGGCTGTCCAAATCCCGGCGGCTCGAAAACCTCATCGCACAGCTCCCTGGGGAGAAGAAGAACGGCCTGTTTGGTAATCTTATCGCCCTGTCACTCGGGCTGACCCCCAACTTTAAATCTAACTTCGACCTGGCCGAAGATGCCAAGCTTCAACTGAGCAAAGACACCTACGATGATGATCTCGACAATCTGCTGGCCCAGATCGGCGACCAGTACGCAGACCTTTTTTTGGCGGCAAAGAACCTGTCAGACGCCATTCTGCTGAGTGATATTCTGCGAGTGAACACGGAGATCACCAAAGCTCCGCTGAGCGCTAGTATGATCAAGCGCTATGATGAGCACCACCAAGACTTGACTTTGCTGAAGGCCCTTGTCAGACAGCAACTGCCTGAGAAGTACAAGGAAATTTTCTTCGATCAGTCTAAAAATGGCTACGCCGGATACATTGACGGCGGAGCAAGCCAGGAGGAATTTTACAAATTTATTAAGCCCATCTTGGAAAAAATGGACGGCACCGAGGAGCTGCTGGTAAAGCTTAACAGAGAAGATCTGTTGCGCAAACAGCGCACTTTCGACAATGGAAGCATCCCCCACCAGATTCACCTGGGCGAACTGCACGCTATCCTCAGGCGGCAAGAGGATTTCTACCCCTTTTTGAAAGATAACAGGGAAAAGATTGAGAAAATCCTCACATTTCGGATACCCTACTATGTAGGCCCCCTCGCCCGGGGAAATTCCAGATTCGCGTGGATGACTCGCAAATCAGAAGAGACCATCACTCCCTGGAACTTCGAGGAAGTCGTGGATAAGGGGGCCTCTGCCCAGTCCTTCATCGAAAGGATGACTAACTTTGATAAAAATCTGCCTAACGAAAAGGTGCTTCCTAAACACTCTCTGCTGTACGAGTACTTCACAGTTTATAACGAGCTCACCAAGGTCAAATACGTCACAGAAGGGATGAGAAAGCCAGCATTCCTGTCTGGAGAGCAGAAGAAAGCTATCGTGGACCTCCTCTTCAAGACGAACCGGAAAGTTACCGTGAAACAGCTCAAAGAAGACTATTTCAAAAAGATTGAATGTTTCGACTCTGTTGAAATCAGCGGAGTGGAGGATCGCTTCAACGCATCCCTGGGAACGTATCACGATCTCCTGAAAATCATTAAAGACAAGGACTTCCTGGACAATGAGGAGAACGAGGACATTCTTGAGGACATTGTCCTCACCCTTACGTTGTTTGAAGATAGGGAGATGATTGAAGAACGCTTGAAAACTTACGCTCATCTCTTCGACGACAAAGTCATGAAACAGCTCAAGAGGCGCCGATATACAGGATGGGGGCGGCTGTCAAGAAAACTGATCAATGGGATCCGAGACAAGCAGAGTGGAAAGACAATCCTGGATTTTCTTAAGTCCGATGGATTTGCCAACCGGAACTTCATGCAGTTGATCCATGATGACTCTCTCACCTTTAAGGAGGACATCCAGAAAGCACAAGTTTCTGGCCAGGGGGACAGTCTTCACGAGCACATCGCTAATCTTGCAGGTAGCCCAGCTATCAAAAAGGGAATACTGCAGACCGTTAAGGTCGTGGATGAACTCGTCAAAGTAATGGGAAGGCATAAGCCCGAGAATATCGTTATCGAGATGGCCCGAGAGAACCAAACTACCCAGAAGGGACAGAAGAACAGTAGGGAAAGGATGAAGAGGATTGAAGAGGGTATAAAAGAACTGGGGTCCCAAATCCTTAAGGAACACCCAGTTGAAAACACCCAGCTTCAGAATGAGAAGCTCTACCTGTACTACCTGCAGAACGGCAGGGACATGTACGTGGATCAGGAACTGGACATCAATCGGCTCTCCGACTACGACGTGGATCATATCGTGCCCCAGTCTTTTCTCAAAGATGATTCTATTGATAATAAAGTGTTGACAAGATCCGATAAAAATAGAGGGAAGAGTGATAACGTCCCCTCAGAAGAAGTTGTCAAGAAAATGAAAAATTATTGGCGGCAGCTGCTGAACGCCAAACTGATCACACAACGGAAGTTCGATAATCTGACTAAGGCTGAACGAGGTGGCCTGTCTGAGTTGGATAAAGCCGGCTTCATCAAAAGGCAGCTTGTTGAGACACGCCAGATCACCAAGCACGTGGCCCAAATTCTCGATTCACGCATGAACACCAAGTACGATGAAAATGACAAACTGATTCGAGAGGTGAAAGTTATTACTCTGAAGTCTAAGCTGGTCTCAGATTTCAGAAAGGACTTTCAGTTTTATAAGGTGAGAGAGATCAACAATTACCACCATGCGCATGATGCCTACCTGAATGCAGTGGTAGGCACTGCACTTATCAAAAAATATCCCAAGCTTGAATCTGAATTTGTTTACGGAGACTATAAAGTGTACGATGTTAGGAAAATGATCGCAAAGTCTGAGCAGGAAATAGGCAAGGCCACCGCTAAGTACTTCTTTTACAGCAATATTATGAATTTTTTCAAGACCGAGATTACACTGGCCAATGGAGAGATTCGGAAGCGACCACTTATCGAAACAAACGGAGAAACAGGAGAAATCGTGTGGGACAAGGGTAGGGATTTCGCGACAGTCCGGAAGGTCCTGTCCATGCCGCAGGTGAACATCGTTAAAAAGACCGAAGTACAGACCGGAGGCTTCTCCAAGGAAAGTATCCTCCCGAAAAGGAACAGCGACAAGCTGATCGCACGCAAAAAAGATTGGGACCCCAAGAAATACGGCGGATTCGATTCTCCTACAGTCGCTTACAGTGTACTGGTTGTGGCCAAAGTGGAGAAAGGGAAGTCTAAAAAACTCAAAAGCGTCAAGGAACTGCTGGGCATCACAATCATGGAGCGATCAAGCTTCGAAAAAAACCCCATCGACTTTCTCGAGGCGAAAGGATATAAAGAGGTCAAAAAAGACCTCATCATTAAGCTTCCCAAGTACTCTCTCTTTGAGCTTGAAAACGGCCGGAAACGAATGCTCGCTAGTGCGGGCGAGCTGCAGAAAGGTAACGAGCTGGCACTGCCCTCTAAATACGTTAATTTCTTGTATCTGGCCAGCCACTATGAAAAGCTCAAAGGGTCTCCCGAAGATAATGAGCAGAAGCAGCTGTTCGTGGAACAACACAAACACTACCTTGATGAGATCATCGAGCAAATAAGCGAATTCTCCAAAAGAGTGATCCTCGCCGACGCTAACCTCGATAAGGTGCTTTCTGCTTACAATAAGCACAGGGATAAGCCCATCAGGGAGCAGGCAGAAAACATTATCCACTTGTTTACTCTGACCAACTTGGGCGCGCCTGCAGCCTTCAAGTACTTCGACACCACCATAGACAGAAAGCGGTACACCTCTACAAAGGAGGTCCTGGACGCCACACTGATTCATCAGTCAATTACGGGGCTCTATGAAACAAGAATCGACCTCTCTCAGCTCGGTGGAGACAGCAGGGCTGACCCCAAGAAGAAGAGGAAGGTGTGATCGATCCAGGCCTCCCAGCTTTCGTCCGTATCATCGGTTTCGACAACGTTCGTCAAGTTCAATGCATCAGTTTCATTGCCCACACACCAGAATCCTACTAAGTTTGAGTATTATGGCATTGGAAAAGCTGTTTTCTTCTATCATTTGTTCTGCTTGTAATTTACTGTGTTCTTTCAGTTTTTGTTTTCGGACATCAAAATGCAAATGGATGGATAAGAGTTAATAAATGATATGGTCCTTTTGTTCATTCTCAAATTATTATTATCTGTTGTTTTTACTTTAATGGGTTGAATTTAAGTAAGAAAGGAACTAACAGTGTGATATTAAGGTGCAATGTTAGACATATAAAACAGTCTTTCACCTCTCTTTGGTTATGTCTTGAATTGGTTTGTTTCTTCACTTATCTGTGTAATCAAGTTTACTATGAGTCTATGATCAAGTAATTATGCAATCAAGTTAAGTACAGTATAGGCTTTTTGTGTCGAGGGGGTACCGAGTCGAGGAATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGGGTACCGAGCTCGAATTCAATTCGGCGTTAATTCAGTACATTAAAAACGTCCGCAATGTGTTATTAAGTTGTCTAAGCGTCAATTTGTTTACACCACAATATATCCTGCCACCAGCCAGCCAACAGCTCCCCGACCGGCAGCTCGGCACAAAATCACCACTCGATACAGGCAGCCCATCAGTCCGGGACGGCGTCAGCGGGAGAGCCGTTGTAAGGCGGCAGACTTTGCTCATGTTACCGATGCTATTCGGAAGAACGGCAACTAAGCTGCCGGGTTTGAAACACGGATGATCTCGCGGAGGGTAGCATGTTGATTGTAACGATGACAGAGCGTTGCTGCCTGTGATCAATTCGGGCACGAACCCAGTGGACATAAGCCTCGTTCGGTTCGTAAGCTGTAATGCAAGTAGCGTAACTGCCGTCACGCAACTGGTCCAGAACCTTGACCGAACGCAGCGGTGGTAACGGCGCAGTGGCGGTTTTCATGGCTTCTTGTTATGACATGTTTTTTTGGGGTACAGTCTATGCCTCGGGCATCCAAGCAGCAAGCGCGTTACGCCGTGGGTCGATGTTTGATGTTATGGAGCAGCAACGATGTTACGCAGCAGGGCAGTCGCCCTAAAACAAAGTTAAACATCATGGGGGAAGCGGTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCCCTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACGATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATTTGAGGCGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAAAATCGCGCCGAAGGATGTCGCTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGACAGGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCGCGCGCAGATCAGTTGGAAGAATTTGTCCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAATGTCTAGCTAGAAATTCGTTCAAGCCGACGCCGCTTCGCCGGCGTTAACTCAAGCGATTAGATGCACTAAGCACATAATTGCTCACAGCCAAACTATCAGGTCAAGTCTGCTTTTATTATTTTTAAGCGTGCATAATAAGCCCTACACAAATTGGGAGATATATCATGCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGTATACACTCCGCTATCGCTACGTGACTGGGTCATGGCTGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGGGTGCCTTGATGTGGGCGCCGGCGGTCGAGTGGCGACGGCGCGGCTTGTCCGCGCCCTGGTAGATTGCCTGGCCGTAGGCCAGCCATTTTTGAGCGGCCAGCGGCCGCGATAGGCCGACGCGAAGCGGCGGGGCGTAGGGAGCGCAGCGACCGAAGGGTAGGCGCTTTTTGCAGCTCTTCGGCTGTGCGCTGGCCAGACAGTTATGCACAGGCCAGGCGGGTTTTAAGAGTTTTAATAAGTTTTAAAGAGTTTTAGGCGGAAAAATCGCCTTTTTTCTCTTTTATATCAGTCACTTACATGTGTGACCGGTTCCCAATGTACGGCTTTGGGTTCCCAATGTACGGGTTCCGGTTCCCAATGTACGGCTTTGGGTTCCCAATGTACGTGCTATCCACAGGAAAGAGACCTTTTCGACCTTTTTCCCCTGCTAGGGCAATTTGCCCTAGCATCTGCTCCGTACATTAGGAACCGGCGGATGCTTCGCCCTCGATCAGGTTGCGGTAGCGCATGACTAGGATCGGGCCAGCCTGCCCCGCCTCCTCCTTCAAATCGTACTCCGGCAGGTCATTTGACCCGATCAGCTTGCGCACGGTGAAACAGAACTTCTTGAACTCTCCGGCGCTGCCACTGCGTTCGTAGATCGTCTTGAACAACCATCTGGCTTCTGCCTTGCCTGCGGCGCGGCGTGCCAGGCGGTAGAGAAAACGGCCGATGCCGGGATCGATCAAAAAGTAATCGGGGTGAACCGTCAGCACGTCCGGGTTCTTGCCTTCTGTGATCTCGCGGTACATCCAATCAGCTAGCTCGATCTCGATGTACTCCGGCCGCCCGGTTTCGCTCTTTACGATCTTGTAGCGGCTAATCAAGGCTTCACCCTCGGATACCGTCACCAGGCGGCCGTTCTTGGCCTTCTTCGTACGCTGCATGGCAACGTGCGTGGTGTTTAACCGAATGCAGGTTTCTACCAGGTCGTCTTTCTGCTTTCCGCCATCGGCTCGCCGGCAGAACTTGAGTACGTCCGCAACGTGTGGACGGAACACGCGGCCGGGCTTGTCTCCCTTCCCTTCCCGGTATCGGTTCATGGATTCGGTTAGATGGGAAACCGCCATCAGTACCAGGTCGTAATCCCACACACTGGCCATGCCGGCCGGCCCTGCGGAAACCTCTACGTGCCCGTCTGGAAGCTCGTAGCGGATCACCTCGCCAGCTCGTCGGTCACGCTTCGACAGACGGAAAACGGCCACGTCCATGATGCTGCGACTATCGCGGGTGCCCACGTCATAGAGCATCGGAACGAAAAAATCTGGTTGCTCGTCGCCCTTGGGCGGCTTCCTAATCGACGGCGCACCGGCTGCCGGCGGTTGCCGGGATTCTTTGCGGATTCGATCAGCGGCCGCTTGCCACGATTCACCGGGGCGTGCTTCTGCCTCGATGCGTTGCCGCTGGGCGGCCTGCGCGGCCTTCAACTTCTCCACCAGGTCATCACCCAGCGCCGCGCCGATTTGTACCGGGCCGGATGGTTTGCGACCGTCACGCCGATTCCTCGGGCTTGGGGGTTCCAGTGCCATTGCAGGGCCGGCAGACAACCCAGCCGCTTACGCCTGGCCAACCGCCCGTTCCTCCACACATGGGGCATTCCACGGCGTCGGTGCCTGGTTGTTCTTGATTTTCCATGCCGCCTCCTTTAGCCGCTAAAATTCATCTACTCATTTATTCATTTGCTCATTTACTCTGGTAGCTGCGCGATGTATTCAGATAGCAGCTCGGTAATGGTCTTGCCTTGGCGTACCGCGTACATCTTCAGCTTGGTGTGATCCTCCGCCGGCAACTGAAAGTTGACCCGCTTCATGGCTGGCGTGTCTGCCAGGCTGGCCAACGTTGCAGCCTTGCTGCTGCGTGCGCTCGGACGGCCGGCACTTAGCGTGTTTGTGCTTTTGCTCATTTTCTCTTTACCTCATTAACTCAAATGAGTTTTGATTTAATTTCAGCGGCCAGCGCCTGGACCTCGCGGGCAGCGTCGCCCTCGGGTTCTGATTCAAGAACGGTTGTGCCGGCGGCGGCAGTGCCTGGGTAGCTCACGCGCTGCGTGATACGGGACTCAAGAATGGGCAGCTCGTACCCGGCCAGCGCCTCGGCAACCTCACCGCCGATGCGCGTGCCTTTGATCGCCCGCGACACGACAAAGGCCGCTTGTAGCCTTCCATCCGTGACCTCAATGCGCTGCTTAACCAGCTCCACCAGGTCGGCGGTGGCCCATATGTCGTAAGGGCTTGGCTGCACCGGAATCAGCACGAAGTCGGCTGCCTTGATCGCGGACACAGCCAAGTCCGCCGCCTGGGGCGCTCCGTCGATCACTACGAAGTCGCGCCGGCCGATGGCCTTCACGTCGCGGTCAATCGTCGGGCGGTCGATGCCGACAACGGTTAGCGGTTGATCTTCCCGCACGGCCGCCCAATCGCGGGCACTGCCCTGGGGATCGGAATCGACTAACAGAACATCGGCCCCGGCGAGTTGCAGGGCGCGGGCTAGATGGGTTGCGATGGTCGTCTTGCCTGACCCGCCTTTCTGGTTAAGTACAGCGATAACCTTCATGCGTTCCCCTTGCGTATTTGTTTATTTACTCATCGCATCATATACGCAGCGACCGCATGACGCAAGCTGTTTTACTCAAATACACATCACCTTTTTAGACGGCGGCGCTCGGTTTCTTCAGCGGCCAAGCTGGCCGGCCAGGCCGCCAGCTTGGCATCAGACAAACCGGCCAGGATTTCATGCAGCCGCACGGTTGAGACGTGCGCGGGCGGCTCGAACACGTACCCGGCCGCGATCATCTCCGCCTCGATCTCTTCGGTAATGAAAAACGGTTCGTCCTGGCCGTCCTGGTGCGGTTTCATGCTTGTTCCTCTTGGCGTTCATTCTCGGCGGCCGCCAGGGCGTCGGCCTCGGTCAATGCGTCCTCACGGAAGGCACCGCGCCGCCTGGCCTCGGTGGGCGTCACTTCCTCGCTGCGCTCAAGTGCGCGGTACAGGGTCGAGCGATGCACGCCAAGCAGTGCAGCCGCCTCTTTCACGGTGCGGCCTTCCTGGTCGATCAGCTCGCGGGCGTGCGCGATCTGTGCCGGGGTGAGGGTAGGGCGGGGGCCAAACTTCACGCCTCGGGCCTTGGCGGCCTCGCGCCCGCTCCGGGTGCGGTCGATGATTAGGGAACGCTCGAACTCGGCAATGCCGGCGAACACGGTCAACACCATGCGGCCGGCCGGCGTGGTGGTGTCGGCCCACGGCTCTGCCAGGCTACGCAGGCCCGCGCCGGCCTCCTGGATGCGCTCGGCAATGTCCAGTAGGTCGCGGGTGCTGCGGGCCAGGCGGTCTAGCCTGGTCACTGTCACAACGTCGCCAGGGCGTAGGTGGTCAAGCATCCTGGCCAGCTCCGGGCGGTCGCGCCTGGTGCCGGTGATCTTCTCGGAAAACAGCTTGGTGCAGCCGGCCGCGTGCAGTTCGGCCCGTTGGTTGGTCAAGTCCTGGTCGTCGGTGCTGACGCGGGCATAGCCCAGCAGGCCAGCGGCGGCGCTCTTGTTCATGGCGTAATGTCTCCGGTTCTAGTCGCAAGTATTCTACTTTATGCGACTAAAACACGCGACAAGAAAACGCCAGGAAAAGGGCAGGGCGGCAGCCTGTCGCGTAACTTAGGACTTGTGCGACATGTCGTTTTCAGAAGACGGCTGCACTGAACGTCAGAAGCCGACTGCACTATAGCAGCGGAGGGGTTGGATCaaagtactttaaagtactttaaagtactttAAAGTACTTTGATCCCGAGGGGAACCCTGTGGTTGGCATGCACATACAAATGGACGAACGGATAAACCTTTTCACGCCCTTTTAAATATCCGATTATTCTAATAAACGCTCTTTTCTCTTAG// Caution:1. This product is FOR RESEARCH USE ONLY!2….

Continue Reading pHDE-AtU626-lpa1-ipk-ipk1A(mays)-sgRNA-mCherry-UBQ-35S-Cas9 Plasmid

Solved Identify the statement that is CORRECT about

Identify the statement that is CORRECT about CRISPR–Cas9 mediated genome editing: Select an answer and submit. For keyboard navigation, use the up/down arrow keys to select an answer. a tracrRNA contains the sequence that anneals to target DNA. b PAM sequence must follow the spacer sequence on the single guide…

Continue Reading Solved Identify the statement that is CORRECT about

Addgene: pDM002-sgRNA-lenti-ZeoR

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications. For your Materials & Methods section: pDM002-sgRNA-lenti-ZeoR was a gift from Britt Glaunsinger (Addgene plasmid # 200060…

Continue Reading Addgene: pDM002-sgRNA-lenti-ZeoR

Addgene: pX459-HypaCas9-mR2-TUBA1B_sgRNA Sequences

> Addgene NGS Result GAGGGCCTATTTCCCATGATTCCTTCATATTTGCATATACGATACAAGGCTGTTAGAGAGATAATTGGAA TTAATTTGACTGTAAACACAAAGATATTAGTACAAAATACGTGACGTAGAAAGTAATAATTTCTTGGGTA GTTTGCAGTTTTAAAATTATGTTTTAAAATGGACTATCATATGCTTACCGTAACTTGAAAGTATTTCGAT TTCTTGGCTTTATATATCTTGTGGAAAGGACGAAACACCGGATGCACTCACGCTGCGGGAGTTTTAGAGC TAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT TTGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTTTTAGCGCGTGCGCCAATTCTGCA GACAAATGGCTCTAGAGGTACCCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGA CCCCCGCCCATTGACGTCAATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATG ACGGTAAATGGCCCGCCTGGCATTGTGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCAGTACAT CTACGTATTAGTCATCGCTATTACCATGGTCGAGGTGAGCCCCACGTTCTGCTTCACTCTCCCCATCTCC CCCCCCTCCCCACCCCCAATTTTGTATTTATTTATTTTTTAATTATTTTGTGCAGCGATGGGGGCGGGGG GGGGGGGGGGGCGCGCGCCRGGSGGGGSGGGGSGGGGSGRGGGGSGGGGSGGGGSGAGGCGGAGAGGTGC GGCGGCAGCCAATCAGAGCGGCGCGCTCCGAAAGTTTCCTTTTATGGCGAGGCGGCGGCGGCGGCGGCCC TATAAAAAGCGAAGCGCGCGGCGGGCGGGAGTCGCTGCGCGCTGCCTTCGCCCCGTGCCCCGCTCCGCCG CCGCCTCGCGCCGCCCGCCCCGGCTCTGACTGACCGCGTTACTCCCACAGGTGAGCGGGCGGGACGGCCC TTCTCCTCCGGGCTGTAATTAGCTGAGCAAGAGGTAAGGGTTTAAGGGATGGTTGGTTGGTGGGGTATTA ATGTTTAATTACCTGGAGCACCTGCCTGAAATCACTTTTTTTCAGGTTGGACCGGTGCCACCATGGACTA TAAGGACCACGACGGAGACTACAAGGATCATGATATTGATTACAAAGACGATGACGATAAGATGGCCCCA AAGAAGAAGCGGAAGGTCGGTATCCACGGAGTCCCAGCAGCCGACAAGAAGTACAGCATCGGCCTGGACA TCGGCACCAACTCTGTGGGCTGGGCCGTGATCACCGACGAGTACAAGGTGCCCAGCAAGAAATTCAAGGT GCTGGGCAACACCGACCGGCACAGCATCAAGAAGAACCTGATCGGAGCCCTGCTGTTCGACAGCGGCGAA ACAGCCGAGGCCACCCGGCTGAAGAGAACCGCCAGAAGAAGATACACCAGACGGAAGAACCGGATCTGCT ATCTGCAAGAGATCTTCAGCAACGAGATGGCCAAGGTGGACGACAGCTTCTTCCACAGACTGGAAGAGTC CTTCCTGGTGGAAGAGGATAAGAAGCACGAGCGGCACCCCATCTTCGGCAACATCGTGGACGAGGTGGCC TACCACGAGAAGTACCCCACCATCTACCACCTGAGAAAGAAACTGGTGGACAGCACCGACAAGGCCGACC TGCGGCTGATCTATCTGGCCCTGGCCCACATGATCAAGTTCCGGGGCCACTTCCTGATCGAGGGCGACCT GAACCCCGACAACAGCGACGTGGACAAGCTGTTCATCCAGCTGGTGCAGACCTACAACCAGCTGTTCGAG GAAAACCCCATCAACGCCAGCGGCGTGGACGCCAAGGCCATCCTGTCTGCCAGACTGAGCAAGAGCAGAC GGCTGGAAAATCTGATCGCCCAGCTGCCCGGCGAGAAGAAGAATGGCCTGTTCGGAAACCTGATTGCCCT GAGCCTGGGCCTGACCCCCAACTTCAAGAGCAACTTCGACCTGGCCGAGGATGCCAAACTGCAGCTGAGC AAGGACACCTACGACGACGACCTGGACAACCTGCTGGCCCAGATCGGCGACCAGTACGCCGACCTGTTTC TGGCCGCCAAGAACCTGTCCGACGCCATCCTGCTGAGCGACATCCTGAGAGTGAACACCGAGATCACCAA GGCCCCCCTGAGCGCCTCTATGATCAAGAGATACGACGAGCACCACCAGGACCTGACCCTGCTGAAAGCT CTCGTGCGGCAGCAGCTGCCTGAGAAGTACAAAGAGATTTTCTTCGACCAGAGCAAGAACGGCTACGCCG GCTACATTGACGGCGGAGCCAGCCAGGAAGAGTTCTACAAGTTCATCAAGCCCATCCTGGAAAAGATGGA CGGCACCGAGGAACTGCTCGTGAAGCTGAACAGAGAGGACCTGCTGCGGAAGCAGCGGACCTTCGACAAC GGCAGCATCCCCCACCAGATCCACCTGGGAGAGCTGCACGCCATTCTGCGGCGGCAGGAAGATTTTTACC CATTCCTGAAGGACAACCGGGAAAAGATCGAGAAGATCCTGACCTTCCGCATCCCCTACTACGTGGGCCC TCTGGCCAGGGGAAACAGCAGATTCGCCTGGATGACCAGAAAGAGCGAGGAAACCATCACCCCCTGGAAC TTCGAGGAAGTGGTGGACAAGGGCGCTTCCGCCCAGAGCTTCATCGAGCGGATGACCAACTTCGATAAGA ACCTGCCCAACGAGAAGGTGCTGCCCAAGCACAGCCTGCTGTACGAGTACTTCACCGTGTATAACGAGCT GACCAAAGTGAAATACGTGACCGAGGGAATGAGAAAGCCCGCCTTCCTGAGCGGCGAGCAGAAAAAGGCC ATCGTGGACCTGCTGTTCAAGACCAACCGGAAAGTGACCGTGAAGCAGCTGAAAGAGGACTACTTCAAGA AAATCGAGTGCTTCGACTCCGTGGAAATCTCCGGCGTGGAAGATCGGTTCAACGCCTCCCTGGGCACATA CCACGATCTGCTGAAAATTATCAAGGACAAGGACTTCCTGGACAATGAGGAAAACGAGGACATTCTGGAA…

Continue Reading Addgene: pX459-HypaCas9-mR2-TUBA1B_sgRNA Sequences

Cas9 is mostly orthogonal to human systems of DNA break sensing and repair

Fig 1. Cleavage of the oligonucleotide or the plasmid substrates by Cas9/sgRNA in the presence of PARP1 and PARP2. Cas9/sgRNA (10 nM) was incubated with 32P-labelled dsDNA1*/2 or dsDNA1/2* (10 nM; A, B) or with pLK1 DNA (10 ng/μl; C, D) and the indicated amounts of NAD+, PARP1 (A, C)…

Continue Reading Cas9 is mostly orthogonal to human systems of DNA break sensing and repair

Precise base editing without unintended indels in human cells and mouse primary myoblasts

Base editors cause unintended indels at the target sites Several types of evolved base editors based on the CRISPR system have been developed for more accurate and efficient genome engineering21,37. Among these, AncBE4max and ABEmax were evolved by modifying codon usage, NLSs, and ancestral deaminase reconstructions21. These modifications greatly improve…

Continue Reading Precise base editing without unintended indels in human cells and mouse primary myoblasts

CRISPR Gene Editing: Cas9 and Beyond

Scientists use the CRISPR-Cas9 system to target a DNA sequence of interest near a protospacer-adjacent motif (PAM). The PAM initiates Cas9-DNA binding, a guide RNA (yellow) invades the double helix (blue) and hybridizes with the target DNA, and Cas9 (red) breaks the unwound double-stranded target DNA. iStock Meletios Verras Stay…

Continue Reading CRISPR Gene Editing: Cas9 and Beyond

Researchers introduce CRISPR-mediated genome and cancer shredding as a conceptual paradigm to treat recurrent gliomas

In a recent study published in Cell Reports, researchers demonstrated clustered regularly interspersed short palindromic repeats (CRISPR)-mediated elimination of glioblastoma (GBM) cells. Study: Targeting the non-coding genome and temozolomide signature enables CRISPR-mediated glioma oncolysis. Image Credit: ART-ur/Shutterstock.com Background Primary GBM is an aggressive tumor that is challenging to treat. The…

Continue Reading Researchers introduce CRISPR-mediated genome and cancer shredding as a conceptual paradigm to treat recurrent gliomas

The double-edge sword of CRISPR application f

image:  Figure 1: Workflow illustration. view more  Credit: 2023 Thomsen. “The Achilles’ heel of CRISPR application is the delivery of sgRNA/Cas9 to the desired tissues.” BUFFALO, NY- November 28, 2023 – A new editorial paper was published in Oncotarget’s Volume 14 on November 27, 2023, entitled, “The double-edge sword of…

Continue Reading The double-edge sword of CRISPR application f

CRISPR’s Dual Role in In Vivo Studies Revealed

“The Achilles’ heel of CRISPR application is the delivery of sgRNA/Cas9 to the desired tissues.” BUFFALO, NY- November 28, 2023 – A new editorial paper was published in Oncotarget’s Volume 14 on November 27, 2023, entitled, “The double-edge sword of CRISPR application for in vivo studies.” In this new paper,…

Continue Reading CRISPR’s Dual Role in In Vivo Studies Revealed

CRISPR-created strawberries that stay firmer and fresher longer could revolutionize fruit industry

The cultivated strawberry (Fragaria × ananassa, Duch.) is one of the Rosaceae family renowned for its flavor and health benefits, making it an important agricultural commodity. However, its soft texture leads to a brief shelf life and consequent economic losses. Current breeding aims to enhance firmness without compromising quality, but…

Continue Reading CRISPR-created strawberries that stay firmer and fresher longer could revolutionize fruit industry

sgRNA Synthesis Reagents and Kits Products

Whether you are performing your first cloning experiment or constructing multi-fragment DNA assemblies, NEB® has the solution for you. Our high quality reagents are available for every workflow, including popular DNA assembly methods such as NEBuilder® HiFi DNA Assembly and NEBridge® Golden Gate Assembly. We also offer solutions for automation, site-directed…

Continue Reading sgRNA Synthesis Reagents and Kits Products

Solved How do you determine the volumes of each needed? Lab

How do you determine the volumes of each needed? Lab 4: Cloning sgRNA for CRISPR/Cas9 gene editing, Part 1a A. Digest pML104 1. Restriction Digest Note: In general, pipette the largest volume of a reaction first, and the restriction enzyme is ALWAYS added last. When you are pipetting small volumes (1–2 \mu…

Continue Reading Solved How do you determine the volumes of each needed? Lab

Development of mRNA-Directed Delivery – LNP Delivery System

During the COVID-19 pandemic, the success of mRNA vaccines has greatly propelled the development of mRNA therapeutics. mRNA is a negatively charged nucleic acid that serves as a template for protein synthesis in ribosomes. Despite its utility, the instability of mRNA necessitates appropriate carriers for in vivo delivery. Currently, lipid nanoparticles (LNPs) are…

Continue Reading Development of mRNA-Directed Delivery – LNP Delivery System

Novaseq read coverage needed for demultiplexing

Novaseq read coverage needed for demultiplexing 0 Hi, I am a new graduate student in biology and am relatively new to sequencing in general. I am planning on doing a genome-wide CRISPR screen over many days. I plan to extract genomic DNA from each condition and amplify the sg region…

Continue Reading Novaseq read coverage needed for demultiplexing

IJMS | Free Full-Text | CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy

1. Introduction Recently, the morbidity and mortality rates of cancer have been increasing rapidly, posing a significant threat to human health. Cancer, a refractory and multifaceted disease, fundamentally originates from a cumulative series of mutations in the cellular genome and epigenome. These mutations activate oncogenes and deactivate tumor suppressors, leading…

Continue Reading IJMS | Free Full-Text | CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy

Newly identified SARS-CoV-2 infection pathway provides clues to severe COVID-19 cases and obesity link

The 3′-end of SARS-CoV-2 genome bears an inducible RNA element. a Positive (+) strand SARS-CoV-2 genome is transcribed into nested subgenomic (sg) RNAs, all containing identical 5′-leaders and 3′-ends; schematic adapted with permission9. b Top: schematic of sgRNA reporter with SARS-CoV-2 5′-leader and 3′-end. Bottom: Effect of agonists on sgRNA…

Continue Reading Newly identified SARS-CoV-2 infection pathway provides clues to severe COVID-19 cases and obesity link

CRISPR/Cas9 editing enhances fruit firmness and extends shelf life

Susceptibility to Botrytis in wild type and FaPG1 edited line #13. Credit: Horticulture Research The cultivated strawberry (Fragaria × ananassa, Duch.) is one of the Rosaceae family renowned for its flavor and health benefits, making it an important agricultural commodity. However, its soft texture leads to a brief shelf life…

Continue Reading CRISPR/Cas9 editing enhances fruit firmness and extends shelf life

Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models

Approximately 10% of Cystic Fibrosis (CF) patients, particularly those with CF transmembrane conductance regulator (CFTR) gene nonsense mutations, lack effective treatments. The potential of gene correction therapy through delivery of the CRISPR/Cas system to CF-relevant organs/cells is hindered by the lack of efficient genome editor delivery carriers. Herein, we report…

Continue Reading Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models

CRISPR Revisited: Quantum Biology and AI Merge Make Genome Editing Processes Revolutionary; and (It): Morphology & Genome Editing Machines

A group of scientists at Oak Ridge National Laboratory have developed new techniques for editing microbial genomes, including use of CRISPR Cas9 technology based on quantum biology and understandable artificial intelligence, in hopes of enabling more precise genetic modifications in microbes and expanding the renewable energy and chemical manufacturing opportunities….

Continue Reading CRISPR Revisited: Quantum Biology and AI Merge Make Genome Editing Processes Revolutionary; and (It): Morphology & Genome Editing Machines

CRISPR-broad: combined design of multi-targeting gRNAs and broad, multiplex target finding

CRISPR-broad framework We developed a procedural pipeline for detecting gRNAs and implemented this in Python as a standalone application (Fig. 1a). For speeding up gRNA selection, we employed multithreading and used big data Python module Pandas. This allowed splitting millions of short sequences for mapping and processing large numbers of uncompressed…

Continue Reading CRISPR-broad: combined design of multi-targeting gRNAs and broad, multiplex target finding

Addgene: pAAV-FLEX-SaCas9-U6-sgRNA Citations

Originally described in: Conditional Single Vector CRISPR/SaCas9 Viruses for Efficient Mutagenesis in the Adult Mouse Nervous System.Hunker AC, Soden ME, Krayushkina D, Heymann G, Awatramani R, Zweifel LS Cell Rep. 2020 Mar 24;30(12):4303-4316.e6. doi: 10.1016/j.celrep.2020.02.092. PubMed Journal Articles Citing pAAV-FLEX-SaCas9-U6-sgRNA Articles CRISPR/SaCas9 mutagenesis of stromal interaction molecule 1 in proopiomelanocortin…

Continue Reading Addgene: pAAV-FLEX-SaCas9-U6-sgRNA Citations

Solved Table 3 lists the four experimental samples (A, B, C,

Transcribed image text: Table 3 lists the four experimental samples (A, B, C, and D) that you will be working with as well the conditions under which they will be grown. During the activity, each sample will be transformed withthe plasmids indicated in the Plasmids column. Table 3. Experimental samples….

Continue Reading Solved Table 3 lists the four experimental samples (A, B, C,

Solved HW 16. CRISPR review Homework – Unanswered – Due

Transcribed image text: HW 16. CRISPR review Homework – Unanswered – Due Today, 11:59 PM In CRISPR, what is the role of small guide RNA (sgRNA)? Select an answer and submit. For keyboard navigation, use the up/down arrow keys to select an answer. a In prokaryotes, sgRNA guides antibodies to…

Continue Reading Solved HW 16. CRISPR review Homework – Unanswered – Due

Scientists use quantum biology, AI to sharpen

image:  ORNL scientists developed a method that improves the accuracy of the CRISPR Cas9 gene editing tool used to modify microbes for renewable fuels and chemicals production. This research draws on the lab’s expertise in quantum biology, artificial intelligence and synthetic biology view more  Credit: Philip Gray/ORNL, U.S. Dept. of…

Continue Reading Scientists use quantum biology, AI to sharpen

CRISPR Results Interpretation Conditions of the E.

Transcribed image text: CRISPR Results Interpretation Conditions of the E. coli cells in each starter plate Questions that will help you predict the experiment results: 3. Will non-transformed bacterial cells grow on the KIX/SPT plates? Yes (No (circle the answer) 4. Where do the bacterial cells obtain the donor template…

Continue Reading CRISPR Results Interpretation Conditions of the E.

D. Based on the plasmid that will be added to each sample, fill in the sgRNA and Donor DNA columns with “+” or “-” to indicate which components those bacteria will have. E. Predict any changes that may occur in the lacZ gene during the laboratory activity for each sample. Record your answers in Table 3. Following transformation, each sample will be spread on LB agar plates that contain additives and incubated to allow colony formation. Table 4. Bacterial plate cultures. Plate 1|c Plate Additives Growth Expected? (Yes/No) A IPTG, X-gal, spectinomycin B IPTG, X-gal, spectinomycin C IPTG, X-gal, spectinomycin D IPTG, X-gal, spectinomycin F. Based on your answers to the previous questions, fill in Table 4 with your predictions of whether there will be bacterial growth on each plate.

1) You have 4 strains of Hfr, an F plasmid has inserted intoeach of these 4 E. coli’s chromosomes in differentlocations. When these strands start mating with F-bacteria, you are able to determine that the bacterial genes aretransferred in the following orders:Strain 1: Q W D M TStrain 2: A…

Continue Reading D. Based on the plasmid that will be added to each sample, fill in the sgRNA and Donor DNA columns with “+” or “-” to indicate which components those bacteria will have. E. Predict any changes that may occur in the lacZ gene during the laboratory activity for each sample. Record your answers in Table 3. Following transformation, each sample will be spread on LB agar plates that contain additives and incubated to allow colony formation. Table 4. Bacterial plate cultures. Plate 1|c Plate Additives Growth Expected? (Yes/No) A IPTG, X-gal, spectinomycin B IPTG, X-gal, spectinomycin C IPTG, X-gal, spectinomycin D IPTG, X-gal, spectinomycin F. Based on your answers to the previous questions, fill in Table 4 with your predictions of whether there will be bacterial growth on each plate.

Scientists use quantum biology, AI to sharpen genome editing tool

Graphical abstract. Credit: Nucleic Acids Research (2023). DOI: 10.1093/nar/gkad736 Scientists at Oak Ridge National Laboratory have used their expertise in quantum biology, artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that can be modified to produce renewable fuels and chemicals. CRISPR…

Continue Reading Scientists use quantum biology, AI to sharpen genome editing tool

Solved CRISPR Results Interpretation Conditions of the E.

Transcribed image text: CRISPR Results Interpretation Conditions of the E. coll cells in each starter plate Questions that will help you predict the experiment results: 3. Will non-transformed bacterial cells grow on the KIX/SPT plates? Yes/No (circle the answer) 4. Where do the bacterial cells obtain the donor template DNA…

Continue Reading Solved CRISPR Results Interpretation Conditions of the E.

Researchers capture high-resolution images of magnesium ions interacting with CRISPR gene-editing enzyme

AceCas9 and its metal dependence. a, Top: domain organization of AceCas9 shown as colored blocks in the direction from the N terminus to the C terminus. The regions corresponding to the structural domains are colored and labeled, and the relevant residues are labeled. RuvC-I–RuvC-III, discontinuous segments of the RuvC domain;…

Continue Reading Researchers capture high-resolution images of magnesium ions interacting with CRISPR gene-editing enzyme

CRISPR-Cas9 gene editing in liver disease

Introduction to CRISPR-Cas9 Gene EditingLiver disease: the need for innovative treatmentsCRISPR-Cas9 applications in liver diseasePrecision medicine and personalized treatmentFuture prospects and research directionsrefer to further reading CRISPR-Cas9 gene editing has great potential in the field of precision medicine for liver diseases. This innovative technology allows researchers to precisely modify genes…

Continue Reading CRISPR-Cas9 gene editing in liver disease

CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines

Rawla, P., Sunkara, T. & Gaduputi, V. Epidemiology of pancreatic cancer: Global trends, etiology and risk factors. World J. Oncol. 10, 10–27 (2019). Article  PubMed  PubMed Central  Google Scholar  Lambert, A. et al. An update on treatment options for pancreatic adenocarcinoma. Ther. Adv. Med. Oncol. 11, 1758835919875568 (2019). Article  PubMed …

Continue Reading CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines

CRISPR/Cas9 Genome Editing for Disease Resistance in Plants

Genome editing, particularly the revolutionary CRISPR/Cas9 technology, has emerged as a game-changer in enhancing plant traits. By offering a more efficient alternative to traditional breeding methods, it holds immense promise in addressing critical challenges such as disease resistance. In this context, a recent research paper titled “CRISPR/Cas9-mediated gene editing to…

Continue Reading CRISPR/Cas9 Genome Editing for Disease Resistance in Plants

gRNA transfection into cells stably expressing Cas9

Yes, I do it regularly, both cr/tracr RNA and sgRNA. I use NIH3T3 cells expressing Cas9 (or 293T cells expressing Cas9) and transfect 1ug of sgRNA or ~ .4ugcrRNA/.6ugtracrRNA with 2.4ul Lipofectamine 3000 into a well of a 6 well plate. 293T cells don’t seem to take up the RNA…

Continue Reading gRNA transfection into cells stably expressing Cas9

A new era of precision genome editing with CRISPR

GUS/LUC dual reporter system for detecting CRISPRa efficacy. (a) CRISPRa construct design for OsTRP-like and OsCCR1 genes. (b)Reporter construct design for OsTRP-like and OsCCR1 promoters. (c) CRISPRa efficiency measurement using two reporter genes, GUS and LUC,in Arabidopsis protoplasts. Bar charts represent mean ± sd (n = 3 three independent protoplast…

Continue Reading A new era of precision genome editing with CRISPR

Unlocking the genetic potential of poplars: A

The Populus genus, commonly known as poplars, cottonwoods, and aspens, consists of approximately 30 tree species native to the northern hemisphere. Because of their diverse usages in landscape, agriculture, bioenergy, and industry, Populus species have been the focus of many tree breeding and genetic improvement programs. Modern biotechnologies, including both genomics and genetic…

Continue Reading Unlocking the genetic potential of poplars: A

Researchers use CRISPR to create bird-flu resistant chickens

The seasons are changing. Winter is coming. But in the darker days ahead, we still have plenty of scientific breakthroughs to celebrate.  Bird flu has been appearing in many media headlines as of late. It is highly infectious and considered by the World Health organization to be a potential pandemic…

Continue Reading Researchers use CRISPR to create bird-flu resistant chickens

[Rapamycin mediated caspase 9 homodimerization to safeguard human pluripotent stem cell therapy]

Human induced pluripotent stem cells (hiPSCs) are promising in regenerative medicine. However, the pluripotent stem cells (PSCs) may form clumps of cancerous tissue, which is a major safety concern in PSCs therapies. Rapamycin is a safe and widely used immunosuppressive pharmaceutical that acts through heterodimerization of the FKBP12 and FRB…

Continue Reading [Rapamycin mediated caspase 9 homodimerization to safeguard human pluripotent stem cell therapy]

GPP Web Portal – Gene Details

Gene: Human LOC642131 (642131) immunoglobulin IGHV1OR15-3-like pseudogene Source: NCBI, updated 2019-09-11 Taxon: Homo sapiens (human) Chromosome: 15 Wildtype Transcripts: NR_135667.1 Additional Resources: NBCI Gene record: LOC642131 (642131) NCBI Gene records for discontinued versions of this gene: LOC102724835 (102724835) sgRNA constructs originally intended to target this gene (CRISPRko, NGG PAM) NOTE:…

Continue Reading GPP Web Portal – Gene Details

Intrinsic Targeting of Host RNA by Cas13: Implications and Challenges

A recent study published in Nature Biomedical Engineering sheds light on the previously unknown ability of Cas13 to intrinsically target host RNA in mammalian cells. Cas13 is a member of the type-VI CRISPR-Cas13 systems, which have been widely utilized for various RNA-targeting applications. Cas13 is known to require a single…

Continue Reading Intrinsic Targeting of Host RNA by Cas13: Implications and Challenges

Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand

Amerigo Scientific, as a distributor focused on providing critical products and services to biomedical and life science communities, announced the release of a groundbreaking selection of CRISPR/Cas enzymes to its extensive life science portfolio, aimed at further expanding the vast potential of the CRISPR toolbox. This addition brings cutting-edge genetic…

Continue Reading Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand

Comparison of methylation estimates obtained via MinION nanopore sequencing and sanger bisulfite sequencing in the TRPA1 promoter region | BMC Medical Genomics

Repeated measurements in one DNA sample revealed congruent results for methylation calling between the methods Sanger bisulfite and nanopore sequencing Mean methylation rates and the methylation rates of individual replicates were congruent between bisulfite and nanopore sequencing (Fig. 1), although the number of calls per site varied in nanopore sequencing. The…

Continue Reading Comparison of methylation estimates obtained via MinION nanopore sequencing and sanger bisulfite sequencing in the TRPA1 promoter region | BMC Medical Genomics

Cas13’s Intrinsic Targeting of Host RNA Limits Its Utility

Cas13 is capable of intrinsically targeting host RNA in mammalian cells through mechanisms that were not previously understood. Through transcript-specific mechanisms that are independent of the CRISPR RNA sequence and dynamically dependent on the conformational state of Cas13, Cas13 can also cleave host RNA. This effect is demonstrated by a…

Continue Reading Cas13’s Intrinsic Targeting of Host RNA Limits Its Utility

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 – Fingerprint — University of Texas Southwestern Medical Center Sort by Weight Alphabetically Medicine & Life Sciences Guide RNA 100% Clustered Regularly Interspaced Short Palindromic Repeats 82% Genome 32% Genomic Library 30% Human Genome 25% Libraries 21% Engineering…

Continue Reading Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

CRISPR sgRNA Cloning & Control Vectors

  The CRISPR/Cas9 system can be used for knocking out gene expression in vivo or in vitro by using the combination of a sgRNA (single guide RNA) along with Cas9 (dCas9) nuclease. Achieve permanent 100% knockout in your cell line by using Cellecta´s lentivirus-based CRISPR system. Expression of the sgRNA and Cas9…

Continue Reading CRISPR sgRNA Cloning & Control Vectors

Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens

Introduction Cancer cells are characterized by unrestrained proliferation and dysregulated growth, which lead to the formation of malignant neoplasms (Hanahan & Weinberg, 2023). The development and progression of cancer have been linked to the dysregulation of multiple signaling pathways, including MAPK/ERK, Wnt/β-catenin, PI3K/AKT/mTOR, and NF-kB, which are among crucial pathways…

Continue Reading Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens

Inflammatory cell death, PANoptosis, screen identifies host factors in coronavirus innate immune response as therapeutic targets

Dong, E., Du, H. & Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 20, 533–534 (2020). Article  CAS  PubMed  PubMed Central  Google Scholar  Tan, W. et al. A novel coronavirus genome identified in a cluster of pneumonia cases – Wuhan, China 2019–2020. China…

Continue Reading Inflammatory cell death, PANoptosis, screen identifies host factors in coronavirus innate immune response as therapeutic targets

Transcriptional regulation and overexpression of GST cluster enhances pesticide resistance in the cotton bollworm, Helicoverpa armigera (Lepidoptera: Noctuidae)

Bras, A., Roy, A., Heckel, D. G., Anderson, P. & Green, K. K. Pesticide resistance in arthropods: ecology matters too. Ecol. Lett. 25, 1746–1759 (2022). Article  PubMed  PubMed Central  Google Scholar  Chen, Y. H. & Schoville, S. D. Editorial overview: ecology: ecological adaptation in agroecosystems: novel opportunities to integrate evolutionary…

Continue Reading Transcriptional regulation and overexpression of GST cluster enhances pesticide resistance in the cotton bollworm, Helicoverpa armigera (Lepidoptera: Noctuidae)

CRISPR-Cas12a test strip (CRISPR/CAST) package: In-situ detection of Brucella from infected livestock | BMC Veterinary Research

Infections caused by Brucella have emerged as a considerable threat worldwide, particularly in vast amounts of livestock. It is essential to eradicate and control Brucella infections in livestock from the source. In addition, earlier detection and timely culling are equally important. Consequently, the screening used for livestock must be accurate, sensitive, specific, simple,…

Continue Reading CRISPR-Cas12a test strip (CRISPR/CAST) package: In-situ detection of Brucella from infected livestock | BMC Veterinary Research

Plants | Free Full-Text | Guidelines for Performing CRISPR/Cas9 Genome Editing for Gene Validation and Trait Improvement in Crops

2.2. Design of Guide RNAs The purpose of this step is to design and select sgRNAs that will create the desirable edits in the target areas of the genome with high efficiency. Currently, there are many online software tools (online software without the need to be installed) for the design…

Continue Reading Plants | Free Full-Text | Guidelines for Performing CRISPR/Cas9 Genome Editing for Gene Validation and Trait Improvement in Crops

Cellecta, Inc. Launches Genome-Wide CRISPR Chicken and Pig Knockout Libraries

CRISPR screening libraries for chicken and pig allow the study of gene disruptions in a single experiment to enable improved breeding and more MOUNTAIN VIEW, Calif., Oct. 9, 2023 /PRNewswire/ — Cellecta, Inc. today announced the release of new pooled, single-module, CRISPR genome-wide knockout libraries for chicken (Gallus gallus) and…

Continue Reading Cellecta, Inc. Launches Genome-Wide CRISPR Chicken and Pig Knockout Libraries

“Argonaute 4 promotes genomic methylation” by Kanwalat Chalertpet

Other Title (Parallel Title in Other Language of ETD) โปรตีนอะโกรนอท 4 กระตุ้นการเกิดเมทิลเลชั่นของจีโนม First Advisor Apiwat Mutirangura Faculty/College Graduate School (บัณฑิตวิทยาลัย) Degree Name Doctor of Philosophy Degree Level Doctoral Degree Degree Discipline Biomedical Sciences DOI 10.58837/CHULA.THE.2019.29 Abstract RNA-directed DNA methylation (RdDM) is the major small RNA-mediated epigenetic pathway in plants. Similar…

Continue Reading “Argonaute 4 promotes genomic methylation” by Kanwalat Chalertpet

Addgene: pX459-HypaCas9-AAVS1_sgRNA

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications. For your Materials & Methods section: pX459-HypaCas9-AAVS1_sgRNA was a gift from Alisa Piekny (Addgene plasmid # 183891…

Continue Reading Addgene: pX459-HypaCas9-AAVS1_sgRNA

IJMS | Free Full-Text | The Effect of Gene Editing by CRISPR-Cas9 of miR-21 and the Indirect Target MMP9 in Metastatic Prostate Cancer

Gene Editing with CRISPR/Cas9 We inserted sgRNAs into the PX-330 plasmid and sequenced them to validate the construct (Figure 1A). Before transfecting the plasmids into PC-3 and DU145 cell lines, we performed a puromycin dose–response curve and observed that 150 µg/mL for 10 days was the ideal concentration and time…

Continue Reading IJMS | Free Full-Text | The Effect of Gene Editing by CRISPR-Cas9 of miR-21 and the Indirect Target MMP9 in Metastatic Prostate Cancer

Role of YAP in hematopoietic differentiation and erythroid lineage specification of human-induced pluripotent stem cells | Stem Cell Research & Therapy

Culture of human-induced pluripotent stem cells (hiPSCs) Human iPSC lines were cultured in Matrigel-coated plates in the Nutristem medium (Corning, USA). Cells were passaged every 5 days by treating with Versene (Thermo Fisher Scientific, USA) for 3–5 min, transferred to freshly prepared Matrigel-coated plates, and cultured under hypoxic conditions with 5% CO2…

Continue Reading Role of YAP in hematopoietic differentiation and erythroid lineage specification of human-induced pluripotent stem cells | Stem Cell Research & Therapy

Custom shRNA Library Cloning

Complex pooled RNAi Libraries for genetic screening Cellecta offers custom shRNA libraries for functional gene screening in addition to their off-shelf shRNA libraries. Custom shRNA libraries for any set of genes in 7 weeks RNA-specific barcodes obviate the need to PCR and sequence difficult hairpin structures Libraries can be provided…

Continue Reading Custom shRNA Library Cloning

Design of an effective sgRNA for CRISPR/Cas9 knock-ins in polyploid Synechocystis sp. PCC 6803

Abstract Synechocystis sp. PCC 6803 (Synechocystis) is a highly promising organism for the production of diverse recombinant chemicals, including biofuels. However, conventional genetic engineering in Synechocystis is challenging due to its highly polyploid genome which not only leads to low product yields but also makes the recombinant organism less reliable…

Continue Reading Design of an effective sgRNA for CRISPR/Cas9 knock-ins in polyploid Synechocystis sp. PCC 6803

Natural antibiotic thiostrepton reveals new hope for inflammatory bowel disease treatment

In a recent study published in Cellular & Molecular Immunology, researchers explored the therapeutic impact of Thiostrepton (TST) on experimental colitis by examining its effects on colon inflammation and determining its targets through various biochemical approaches. They analyzed its influence on gut microbiota, with a focus on its potential as…

Continue Reading Natural antibiotic thiostrepton reveals new hope for inflammatory bowel disease treatment

Specific Modulation of CRISPR Transcriptional Activators through RNA-Sensing Guide RNAs in Mammalian Cells and Zebrafish Embryos

Modular iSBH-sgRNA designs enable spatial separation of spacer and trigger-sensing sequences. A. In second-generation iSBH-sgRNAs, RNA triggers are complementary with the iSBH-sgRNA backfolds, thus sgRNA spacers influence RNA trigger sequences. In modular iSBH-sgRNAs, design constrains were eliminated as triggers are only complementary with the iSBH-sgRNA loop and first 15nt of…

Continue Reading Specific Modulation of CRISPR Transcriptional Activators through RNA-Sensing Guide RNAs in Mammalian Cells and Zebrafish Embryos

Solved CRISPR/CAS9 sgRNA Knockout efficiency (percent) for

CRISPR/CAS9 sgRNA Knockout efficiency (percent) for Gene X strain 1 strain 2 strain 3 strain 4 96 95 96 94 94 95 93 93 93 92 94 94 94 93 96 92 94 97 94 94 95 93 92 96 92 93 93 93 95 92 92 93 94 95…

Continue Reading Solved CRISPR/CAS9 sgRNA Knockout efficiency (percent) for

Prime Medicine Stock: Not Yet Primed For Retail Investment (NASDAQ:PRME)

Richard Drury Prime Medicine (PRME) is another Dr. David Liu biotechnology production with a near-billion dollar valuation and no assets in the clinic. What makes Prime Medicine command such high valuation despite being merely in an IND-enabling stage? Prime Medicine, as the name implies, is developing the relatively new gene…

Continue Reading Prime Medicine Stock: Not Yet Primed For Retail Investment (NASDAQ:PRME)

Orthogonal Validation: A Means To Strengthen Gene Editing and Gene Modulation Research

From RNA interference (RNAi) to CRISPR, there are several methods that researchers can use to manipulate gene function, each with its own strengths and weaknesses. Orthogonal validation – the synergistic use of different methods – makes genetic perturbation studies more robust. Utilizing complementary methods, including RNAi and CRISPR-knockout, -interference and…

Continue Reading Orthogonal Validation: A Means To Strengthen Gene Editing and Gene Modulation Research

Custom sgRNA Library Cloning

Take advantage of Cellecta’s 15+ years of experience making pooled sgRNA Lentiviral Libraries In addition to their ready-to-use, off-the-shelf Genome-Wide CRISPR libraries, Cellecta also provides custom-designed CRISPR sgRNA Pooled Libraries targeting virtually any set of genes and incorporating guide sequences and vector features for a range of screening applications. Custom…

Continue Reading Custom sgRNA Library Cloning

Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Tango Therapeutics, Inc. BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that five abstracts have been selected for poster presentations at the AACR-NCI-EORTC International Conference on Molecular Targets…

Continue Reading Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Single-cell screening of cerebral organoids to identify developmental defects in autism

In a recent study published in Nature, researchers develop the clustered regularly interspaced short palindromic repeats (CRISPR)-human organoids-single-cell ribonucleic acid (RNA) sequencing (CHOOSE) system to identify developmental brain defects in autism. Study: Single-cell brain organoid screening identifies developmental defects in autism. Image Credit: Yurchanka Siarhei / Shutterstock.com Diagnosing autism Autism spectrum disorder (ASD) is…

Continue Reading Single-cell screening of cerebral organoids to identify developmental defects in autism

BioMG2801 Lecture 4 F23.pdf – BioMG2801 Lecture 4 Week 4: September 11 – 15 Lecture 4: Gen II crosses PCR and sequencing primer design DNA

Due: • Assignment 3 by 2:30 PM on your lab THIS week. • Assignment 4 by 2:30 PM on your lab NEXT week.A4 is a longer assignment, plan ahead and give yourself sufficient time to complete.Week 4: September 11 – 15 Assigned Readings Lecture 4:Gen II crosses; PCR and sequencing…

Continue Reading BioMG2801 Lecture 4 F23.pdf – BioMG2801 Lecture 4 Week 4: September 11 – 15 Lecture 4: Gen II crosses PCR and sequencing primer design DNA

Genome-wide promoter responses to CRISPR perturbations of regulators reveal regulatory networks in Escherichia coli

PPTP-seq development and validation PPTP-seq uses plasmid to integrate each CRISPRi-based TF perturbation and each promoter activity reporter into one construct. Each plasmid contains a CRISPRi cassette that constitutively expresses a single guide RNA (sgRNA) to repress a specific TF in the genome19 and a promoter-reporter cassette to measure the…

Continue Reading Genome-wide promoter responses to CRISPR perturbations of regulators reveal regulatory networks in Escherichia coli

sgRNA Synthesis Reagents and Kits

Products and content are covered by one or more patents, trademarks and/or copyrights owned or controlled by New England Biolabs, Inc (NEB). The use of trademark symbols does not necessarily indicate that the name is trademarked in the country where it is being read; it indicates where the content was originally…

Continue Reading sgRNA Synthesis Reagents and Kits

Problem with Mageck paired analysis

Problem with Mageck paired analysis 0 Dear all, I have a matter to submit. I’m trying to do a paired analysis, however, I’m getting this error. Error: incorrect number of dimensions in line 2 (16) compared with the header line (4). Please double-check your read count table file. This is…

Continue Reading Problem with Mageck paired analysis

Broad Files Reply Brief in Interference No. 106,115 Cross-Appeal | McDonnell Boehnen Hulbert & Berghoff LLP

  In its contingent cross-appeal from the Patent Trial and Appeal Board’s (PTAB) adverse decision on priority against Junior Party the University of California/Berkeley, the University of Vienna, and Emmanuelle Charpentier (collectively, “CVC”) in Interference No. 106,115 (directed to CRISPR-mediated gene editing), Senior Party Broad Institute, Harvard University, and MIT…

Continue Reading Broad Files Reply Brief in Interference No. 106,115 Cross-Appeal | McDonnell Boehnen Hulbert & Berghoff LLP

Thymic mimetic cells function beyond self-tolerance

Klein, L., Kyewski, B., Allen, P. M. & Hogquist, K. A. Positive and negative selection of the T cell repertoire: what thymocytes see (and don’t see). Nat. Rev. Immunol. 14, 377–391 (2014). Article  CAS  PubMed  PubMed Central  Google Scholar  Bornstein, C. et al. Single-cell mapping of the thymic stroma identifies…

Continue Reading Thymic mimetic cells function beyond self-tolerance

Gene Editing Tools Based on CRISPR/Cas System and Their Improvement Strategies

     Gene Editing Tools Based on CRISPR/Cas System and Their Improvement Strategies XIN Yuan1,TIAN Kai-ren3,QIAO Jian-jun1,2,3,CAIYIN Qing-ge-le1,2,**() 1 School of…

Continue Reading Gene Editing Tools Based on CRISPR/Cas System and Their Improvement Strategies